Skip to main content
Premium Trial:

Request an Annual Quote

Osiris and Genetica Form Genomics Collaboration On Mesenchymal Cells


BALTIMORE--Osiris Therapeutics has entered into a research collaboration with Genetica, of Cold Spring Harbor, NY, that covers the functional genomics of human mesenchymal stem cells, the progenitors of structural and connective tissues. The collaboration will focus on the discovery of genes that control the growth and differentiation of the cells, to identify potential drug development targets. The companies said the venture takes advantage of Osiris's proprietary position in human mesenchymal stem cells and its expertise in cell and gene therapy, as well as of Genetica's novel genomics technology.

Osiris is engaged in research and development for therapeutic products for the regeneration of human structural and connective tissues through the use of the stem cells.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.